We are live on
!
Find out more
Myriad Genetics
MYGN
MYGN
202 hedge funds and large institutions have $518M invested in Myriad Genetics in 2026 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 75 increasing their positions, 68 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
17% more call options, than puts
Call options by funds: $97K | Put options by funds: $83K
10% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 68
4.97% less ownership
Funds ownership: 98.94% → 93.98% (-5%)
9% less funds holding
Funds holding: 221 → 202 (-19)
9% less capital invested
Capital invested by funds: $568M → $518M (-$49.5M)
33% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 48
Holders
202
Holders Change
-19
Holders Change %
-8.6%
% of All Funds
2.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
75
Reduced
68
Closed
48
Calls
$97K
Puts
$83K
Net Calls
+$14K
Net Calls Change
-$338K
Top Buyers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$6.89M |
| 2 |
HF
HRT Financial
New York
|
+$6.86M |
| 3 |
Jane Street
New York
|
+$5.98M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$5.63M |
| 5 |
GCM
Glenview Capital Management
New York
|
+$4.3M |
Top Sellers
| 1 |
BlackRock
New York
|
-$33.4M |
| 2 |
State Street
Boston,
Massachusetts
|
-$8.04M |
| 3 |
Walleye Capital
New York
|
-$4.16M |
| 4 |
RA
Royce & Associates
New York
|
-$3.72M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.86M |
